CareLit · DOI-Nachweis · Ultraschall in der Medizin - European Journal of Ultrasound
Influence of heterogeneities on liver steatosis evaluation by Fibroscan® (CAP™): relevance of a liver guidance tool
DOI 10.1055/s-0033-1355088
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Sasso, S Audière, L Sandrin, V Miette
ZeitschriftUltraschall in der Medizin - European Journal of Ultrasound
Ausgabe10/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: Controlled Attenuation Parameter (CAP) is a measure of ultrasound attenuation developed to assess steatosis on the Fibroscan®. CAP performance in clinical studies always showed satisfactory results. However, CAP is based on the hypothesis that liver parenchyma is homogeneous whereas it is not everywhere (blood vessel, nodules, etc.). The objective of here is to determine the influence of heterogeneities on…
Zitieren
Zitierempfehlung
M Sasso, S Audière, L Sandrin, V Miette (2013) Influence of heterogeneities on liver steatosis evaluation by Fibroscan® (CAP™): relevance of a liver guidance tool. Ultraschall in der Medizin - European Journal of Ultrasound (10). https://doi.org/10.1055/s-0033-1355088
Mit CareLit weiterarbeiten